Number To Know…5
Executive Summary
Five years ago, BoneSupport signed on Biomet – now Zimmer Biomet – as the exclusive US distributor of its Cerament bone substitute product. The two companies have decided to renew and extend the partnership.
Swedish specialist in injectable bone substitute materials BoneSupport ABsucceeded in getting big ortho player Biomet on board, five years ago in 2012, as its US distribution partner for its Cerament bone void filler. On Mar. 14, the companies – Biomet now having merged with Zimmer – announced they will be extending this partnership. Cerament is approved for orthopedic, trauma and foot and ankle indications. BoneSupport also has Cerament G, a bone void filler that elutes the antibiotic gentamicin, and Cerament V, which elutes vancomycin, which are CE marked but not yet approved in the US.
Meddevicetracker subscribers can find out more about BoneSupport and its pipeline of products here.
Not a subscriber, click here to request your free demo.